RESP — Respiratorius AB (publ) Income Statement
0.000.00%
Last trade - 00:00- SEK12.24m
- SEK12.24m
Annual income statement for Respiratorius AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 April 30th | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 4 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | Interim Report | ARS |
| Standards: | SAS | SAS | SAS | — | SAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0.133 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | 0.872 | 1.55 | 0.75 | 1.26 | 0.484 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 7.07 | 9.55 | 4.36 | 7.83 | 7.51 |
| Operating Profit | -7.07 | -9.55 | -4.23 | -7.83 | -7.51 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -7.47 | -9.64 | -4.23 | -7.83 | -7.57 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -7.47 | -9.64 | -4.23 | -7.83 | -7.57 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -7.47 | -9.64 | -4.23 | -7.83 | -7.57 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -7.47 | -9.64 | -4.23 | -7.83 | -7.57 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -3.48 | -3.96 | -1.33 | -2.46 | -1.48 |
| Dividends per Share |